Bicycling
Conditions
Interventions
This is a randomized, crossover, double-blind, placebo-controlled clinical trial, approved by the Research Ethics Committee of the Federal University of Rio de Janeiro, Macaé Campus, under a substanti
Sponsors
Universidade Federal do Rio de Janeiro (UFRJ)
Universidade Federal do Rio de Janeiro Campus Macaé
Eligibility
Sex/Gender
Male
Age
25 Years to 45 Years
Inclusion criteria
Inclusion criteria: Male sex; age between 25 and 45 years; at least four years of regular cycling practice; no current use of medications that interact with caffeine; and absence of medical conditions, including cardiovascular, gastrointestinal, musculoskeletal or metabolic disorders in the previous three months
Exclusion criteria
Exclusion criteria: Individuals diagnosed with gastritis; hypertension; allergy to supplement components such as flavorings or sweeteners; use of antidepressants or beta blockers; participants who did not correctly follow the experimental protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An increase in the peak power output obtained during the sprints performed in the intermittent exercise protocol on the cycle ergometer is expected;There was a significant increase in maximum power in sprints number 2, 3, and 4 in the caffeine (CAF) condition compared to the placebo (PLA), with p<0.05 | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that in the group supplemented with caffeine, there will be an increase in average power during sprints; a reduction in the Rate of Perceived Exertion (RPE), assessed by the Borg Scale;There was no significant difference between the studied groups (caffeine and placebo) regarding average power in sprints and Perceived Exertion (PE), assessed by the Borg Scale | — |
Countries
Brazil
Contacts
Public ContactBeatriz Gonçalves Ribeiro Ribeiro
Universidade Federal do Rio de Janeiro
Outcome results
None listed